PubMed:15590774 / 126-381 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":255},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":255},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":255},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Small reducing and linear oligo-beta-(1,3)-glucans, which are able to act as phytoallexin elicitors or as immunostimulating agents in anticancer therapy, were synthesized according to an iterative strategy that involved a unique key monosaccharidic donor."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T3","span":{"begin":32,"end":36},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T4","span":{"begin":32,"end":36},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"}],"text":"Small reducing and linear oligo-beta-(1,3)-glucans, which are able to act as phytoallexin elicitors or as immunostimulating agents in anticancer therapy, were synthesized according to an iterative strategy that involved a unique key monosaccharidic donor."}

{"project":"GO-BP","denotations":[{"id":"T3","span":{"begin":32,"end":50},"obj":"http://purl.obolibrary.org/obo/GO_0006074"},{"id":"T6","span":{"begin":32,"end":50},"obj":"http://purl.obolibrary.org/obo/GO_0006075"},{"id":"T9","span":{"begin":32,"end":50},"obj":"http://purl.obolibrary.org/obo/GO_0006076"}],"text":"Small reducing and linear oligo-beta-(1,3)-glucans, which are able to act as phytoallexin elicitors or as immunostimulating agents in anticancer therapy, were synthesized according to an iterative strategy that involved a unique key monosaccharidic donor."}